 In addition, Mesa Labs expects to grant the underwriters a 30-day option to purchase up to an additional 15 million of shares. Mesa Labs intends to use the net proceeds from the offering for general corporate purposes, which may include acquisitions. Jefferies LLC, J.P. Morgan and Evercore Group L.L.C. are acting as joint book-running managers for the offering. 